Science News
from research organizations

Preimplantation Genetic Diagnosis May Pose Neurological Risks

Date:
July 22, 2009
Source:
American Society for Biochemistry and Molecular Biology
Summary:
Preimplantation genetic diagnosis (PGD) has helped many couples conceive healthy children and is generally considered a safe practice. However, a new long-term analysis of PGD in mice suggests that this procedure may increase risks of weight gain and memory decline in adulthood.
Share:
       
FULL STORY

Preimplantation genetic diagnosis (PGD) has helped many couples conceive healthy children and is generally considered a safe practice. However, a new long-term analysis of PGD in mice suggests that this procedure may increase risks of weight gain and memory decline in adulthood.

PGD is used alongside assisted reproduction technologies to ensure couples that may be carriers of genetic disease (e.g. Ashkenazi Jews who have a high incidence of Tay-Sachs among their population) don't pass on defective genes to their children. While PGD is not believed to pose any serious health risks, the procedure does involve manipulating the developing embryo and no rigorous long-term studies have been carried out.

Ran Huo, Qi Zhou and colleagues used a mouse model to examine how a blastomere biopsy, as the key manipulation during the PGD procedure, could affect fetal, neonatal and adult development.

They found that there were no differences in embryo development prior to uterine implantation in the biopsied and control groups, which is consistent with results found in humans. However, following implantation, successful births from biopsied embryos were significantly lower than in controls.

Following birth, the authors tracked many physical and behavioral properties; the two groups of mice were similar in many respects, though mice in the biopsied group on average had higher body weight and poorer memory in maze tests. To get a more detailed picture of these memory defects, the authors performed a proteomic analysis of adult mouse brains; 36 proteins displayed significant differences between biopsied and control groups, 17 of which are closely associated with neurodegenerative disorders like Alzheimers and Down Syndrome.

The authors suggest that the developing nervous system may be sensitive to blastomere biopsy, and that more studies should be performed to address any possible long-term adverse effects of PGD to ensure its safety.


Story Source:

The above story is based on materials provided by American Society for Biochemistry and Molecular Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yu et al. Evaluation of Blastomere Biopsy Using a Mouse Model Indicates the Potential High Risk of Neurodegenerative Disorders in the Offspring. Molecular & Cellular Proteomics, 2009; 8 (7): 1490 DOI: 10.1074/mcp.M800273-MCP200

Cite This Page:

American Society for Biochemistry and Molecular Biology. "Preimplantation Genetic Diagnosis May Pose Neurological Risks." ScienceDaily. ScienceDaily, 22 July 2009. <www.sciencedaily.com/releases/2009/07/090721122857.htm>.
American Society for Biochemistry and Molecular Biology. (2009, July 22). Preimplantation Genetic Diagnosis May Pose Neurological Risks. ScienceDaily. Retrieved May 28, 2015 from www.sciencedaily.com/releases/2009/07/090721122857.htm
American Society for Biochemistry and Molecular Biology. "Preimplantation Genetic Diagnosis May Pose Neurological Risks." ScienceDaily. www.sciencedaily.com/releases/2009/07/090721122857.htm (accessed May 28, 2015).

Share This Page: